NCT06339021View on ClinicalTrials.gov

OCT or Angiography Guided De-escalation of DAPT

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2026

Conditions
Optical Coherence TomographyDual Antiplatelet TherapyAntiplatelet De-escalationNeointimal CoverageST Elevation Myocardial Infarction
Interventions
PROCEDURE

OCT-guided PCI

OCT-guided PCI based on MLD MAX algorithm

PROCEDURE

Conventional angiography-based PCI

Conventional angiography-based PCI

DRUG

DAPT de-escalation

Aspirin and clopidogrel 30 days after DES implantation

DRUG

default DAPT regimen

Aspirin and ticagrelor 30 days after DES implantation

Trial Locations (1)

Unknown

Northern Hospital, Shenyang

All Listed Sponsors
lead

Shenyang Northern Hospital

OTHER

NCT06339021 - OCT or Angiography Guided De-escalation of DAPT | Biotech Hunter | Biotech Hunter